52 Results for "

galectin-3

" in MedChemExpress (MCE) Product Catalog:
Products (52)

52 Results for "galectin-3" in MCE Product Catalog:

20
20 Publications Verification
Cat. No.: HY-114409
CAS No.: 1978336-61-6
Purity:  99.92%
Target:  

Galectin

Research Areas:  

Cancer

GB1107 is a potent, selective, orally active inhibitor of Galectin-3 (Gal-3) with a Kd of 37 nM for human Galectin-3. GB1107 reduces human and mouse lung adenocarcinoma growth and blocks metastasis in the syngeneic model .
loading...
    loading...
13
13 Cited Publications
Cat. No.: HY-19940
CAS No.: 1450824-22-2
Synonyms: TD139; GB0139
Target:  

Galectin

Research Areas:  

Inflammation/Immunology

TD139 is a synthetic galectin-3 inhibitor. TD139 has high affinity for galectin-3 with a Kd of 68 nM, a Kd of 0.22 μM for galectin-1, and a Kd of 38 μM for galectin-7 .
loading...
    loading...
4
4 Cited Publications
Cat. No.: HY-P70309
Purity:  ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: rHugalectin-3; galectin-3; Gal-3; 35 kDa Lectin; Carbohydrate-Binding Protein 35; CBP 35; Galactose-Specific Lectin 3; Galactoside-Binding Protein; GALBP; IgE-Binding Protein; L-31; Laminin-Binding Protein; Lectin L-29; Mac-2 Antigen; LGALS3; MAC2
Species:  
Source:  
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-147041
CAS No.: 1978336-95-6
Purity:  98.87%
Synonyms: GB1211
Target:  

Galectin

Research Areas:  

Inflammation/Immunology Cancer

Selvigaltin (GB1211) is an orally active galectin-3 small molecule inhibitor with an IC50 value of 12 nM in rabbits, showing anti-tumor activity. Selvigaltin decreases galectin-3 levels in the liver and reduces biomarkers of liver function (AST, ALT, bilirubin), inflammation (cells foci) and fibrosis (PSR, SHG), as well as decreasing the mRNA and protein expression of several key inflammation and fibrosis biomarkers (IL6, TGFβ3, SNAI2, collagen). Selvigaltin restores T-cell activity and induces less tumors and metastasis [3] .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-P1592
CAS No.: 848301-94-0
Target:  

Galectin

Research Areas:  

Cancer

G3-C12 is a galectin-3 binding peptide, with Kd of 88 nM, and shows anticancer activity.
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-P1592A
Target:  

Galectin

Research Areas:  

Cancer

G3-C12 (TFA) is a galectin-3 binding peptide, with Kd of 88 nM, and shows anticancer activity.
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-163121
CAS No.: 1096144-06-7
PST3.1a is an orally active and brain-penetrant N-acetylglucosamine glycosyltransferase (MGAT5) inhibitor with a human IC50 of 2 µM. PST3.1a inhibits TGFβR and FAK signaling pathway activity. PST3.1a alters β1,6-GlcNAc N-glycans and microtubule/microfilament integrity, increases OLIG2 expression, and inhibits proliferation, migration, invasiveness, and clonogenic capacities of glioblastoma initiating cells. PST3.1a reduces invasive and proliferative capacity of glioblastoma initiating cells in orthotopic graft models, increases overall survival of orthotopic graft model mice. PST3.1a blunts MGAT5 overexpression, decreases renal fibrosis via collagen 1, collagen 4, and galectin 3 downregulation in a rat chronic kidney disease model. PST3.1a can be used for the research of glioblastoma multiforme and chronic kidney disease .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-P77684
Purity:  ≥ 95%, as determined by Bis-Tris PAGE.
Synonyms: AGE-R3; CBP35; GAL3; Gal-3; galactin-3; GALBPCBP35; galectin3; GALIG; L29; L31; Lectin L-29; LGALS2; LGALS3; Mac-2; MAC2GAL3
Species:  
Source:  
loading...
    loading...
Cat. No.: HY-126854
CAS No.: 32181-59-2
Purity:  99.95%
Synonyms: N-Acetyl-D-lactosamine
N-Acetyllactosamine (N-Acetyl-D-lactosamine), a nitrogen-containing disaccharide, is a galectin-3 inhibitor, which is an important component of various oligosaccharides such as glycoproteins and sialyl Lewis X. N-Acetyllactosamine can be used as the starting material for the synthesis of various oligosaccharides. N-Acetyllactosamine has prebiotic effects [3] .
loading...
    loading...
Cat. No.: HY-101157
CAS No.: 1245823-51-1
Purity:  ≥98.0%
Research Areas:  

Cancer

Propargyl-PEG5-acid is a non-cleavable 5 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs). Propargyl-PEG5-acid can used to synthesize ADC inhibitors of Galectin-3. Propargyl-PEG5-acid is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs . Propargyl-PEG5-acid is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.
loading...
    loading...
Cat. No.: HY-NP165
Synonyms: AGEs
Advanced glycation end products (AGEs) are a series of stable compounds generated through non-enzymatic reactions between reducing sugars and proteins, lipids, or nucleic acids. Advanced glycation end products are often used as targets to evaluate the inhibitory effects of anti-glycation compounds. Advanced glycation end products can be applied to research on diabetes, cardiovascular and cerebrovascular diseases, inflammation, aging, and other conditions [3] .
loading...
    loading...
Cat. No.: HY-114440
CAS No.: 1980787-47-0
Purity:  98.94%
Synonyms: GR-MD-02
Target:  

Galectin Apoptosis

Research Areas:  

Cancer

Belapectin (GR-MD-02) is a Galectin-3 (Gal-3) inhibitor. Belapectin drives tumor-induced immunosuppression by inducing T cell Apoptosis. Belapectin promotes tumor regression and improves survival of tumor-bearing mice through a CD8+ T cell-dependent mechanism. Belapectin binds to Gal-3 with affinity Ki of 2.8 μM .
loading...
    loading...
Cat. No.: HY-146808
CAS No.: 2921603-03-2
Purity:  99.77%
Target:  

Galectin

Research Areas:  

Cancer

Galectin-3 antagonist 1 (compound 15) is a potent and selective Galectin-3 (Gal-3) antagonist with Kd value of 5.3 μM. Meanwhile, Galectin-3 antagonist 1 binds to various Galectin with Kd values of 250 μM (Gal-4N), 18 μM (Gal-4C), 450 μM (Gal-8C), respectively .
loading...
    loading...
Cat. No.: HY-162561
CAS No.: 2573135-31-4
Target:  

Galectin

Research Areas:  

Cancer

GB1908 is a selective and orally active galectin-1 inhibitor with Ki values of 57 nM and 72 nM for human and mouse galectin-1, respectively. GB1908 displays >50-fold selectivity over galectin-3. GB1908 can be used for the study of lung cancer .
loading...
    loading...
Cat. No.: HY-144312
CAS No.: 1989627-40-8
Purity:  99.76%
Target:  

Galectin

Research Areas:  

Metabolic Disease Cancer

Thiobis-β-Galactose-propyne is an effective multivalent galectin-3 (Gal-3) inhibitor. Galectin-3 is involved in many metabolism processes related to cancer. Galectin-3-IN-1 is a click chemistry reagent. It contains an alkyne group that can undergo a copper-catalyzed azide-alkyne cycloaddition (CuAAc) reaction with molecules that have an azide group .
loading...
    loading...
Cat. No.: HY-170510
CAS No.: 2574415-75-9
Target:  

Galectin

Research Areas:  

Cancer

GB2095 is an orally active and selective galectin-3 inhibitor. GB2095 shows superior selectivity for both human (KD = 0.036 μM) and mouse galectin-3 (KD = 0.35 μM) over other galectins (such as h-Gal-1/4N/4C/8N/8C/9N/9C and m-galectin-1). GB2095 inhibits tumor growth in syngeneic mouse models of breast and melanoma cancers. GB2095 can be used for breast and melanoma cancer research .
loading...
    loading...
Cat. No.: HY-N16021
CAS No.: 2260669-09-6
4A-MPLA ammonium is an orally active TLR4 agonist. 4A-MPLA ammonium induces TLR4 endocytosis dependent on Cdc42 and galectin-3, triggering TRIF-mediated signaling and sustained IFN-β production. 4A-MPLA ammonium promotes lipid droplet formation, upregulates interferon-stimulated genes and type I IFN signaling genes, downregulates lysosome/phagosome function genes, and modulates tolerogenic dendritic cell function. 4A-MPLA ammonium can be used for the research of colitis [3].
loading...
    loading...
Cat. No.: HY-144313
CAS No.: 2883648-71-1
Target:  

Galectin

Research Areas:  

Metabolic Disease Cancer

Galectin-3-IN-2 (Compound 9) is a potent multivalent inhibitor of galectin-3 (Gal-3; IC50=8.3 μM). Galectin-3 participates in many cancer-related metabolic processes .
loading...
    loading...
Cat. No.: HY-173235
CAS No.: 2604662-64-6
Galectin-3-IN-6 is a human and murine galectin-3 (Gal-3) inhibitor, with an IC50 of 12 nM against human galectin-3, an IC50 of 12.6 nM against mutant murine galectin-3 (V160A), and a Kd of 13 nM for human galectin-3, as well as oral bioavailability. Galectin-3-IN-6 reduces the levels of liver fibrosis markers type I collagen and α-smooth muscle actin in mouse models of acute liver injury and fibrosis. Galectin-3-IN-6 can be used for the research of acute liver injury and fibrosis .
loading...
    loading...
Cat. No.: HY-P990198

Target:  

Galectin

Research Areas:  

Inflammation/Immunology

Anti-Mouse/Human Mac-2/Galectin-3 Antibody (TIB-166) is a rat-derived anti-mouse/human Mac-2/Galectin-3 IgG2a monoclonal antibody. Anti-Mouse/Human Mac-2/Galectin-3 Antibody (TIB-166) significantly inhibits IL-6 expression (inhibition rates 34.7% and 55.3%). Anti-Mouse/Human Mac-2/Galectin-3 Antibody (TIB-166) is often used for immunoprecipitation, western blot, immunofluorescence, and flow cytometry [3] .
loading...
    loading...